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The Chan-Evans-Lam reaction is a valuable C-N bond forming process. However, aryl 
boronic acid pinacol (BPin) ester reagents can be difficult coupling partners that often deliver 
low yields, in particular in reactions with aryl amines. Herein we report effective reaction 
conditions for the Chan-Evans-Lam amination of aryl BPin with alkyl and aryl amines. A 
mixed MeCN/EtOH solvent system was found to enable effective C-N bond formation using 
aryl amines while EtOH is not required for the coupling of alkyl amines. 
 
Transition metal–mediated C-N bond formation is an essential transformation that enables the 
preparation of valuable amine products.1 The Buchwald–Hartwig reaction2 (mediated by Pd) 
and Chan–Evans–Lam (CEL) reaction3,4 (mediated by Cu) are two related methods that are 
widely practiced. The CEL reaction is particularly favored due to several advantages it can 
offer versus its Pd counterpart, such as the lower cost and toxicity of the metal as well as its 
tolerance of aerobic conditions. This process typically couples a boronic acid with an amine 
under mild conditions to deliver a new C-N bond (Scheme 1) and has seen considerable 
development. Despite this, a significant and routinely encountered problem with the CEL 
amination reaction is that aryl boronic acid pinacol (BPin) esters and aryl amines are 
generally very poor substrates. Enabling the effective amination of aryl BPin esters is highly 
desired due to the increased stability and accessibility of these species with respect to the 
parent boronic acids.4 
In relation to this BPin problem, Hartwig has developed specific reaction conditions for the 
CEL reaction of aryl BPins that are moderately effective with alkyl amines but not with aryl 
amines (Scheme 1a (i)).5 Koninobu has shown alkyl BPin substrates will undergo reaction 
with alkyl and aryl amines; however, aryl BPin species are not tolerated (Scheme 1a (ii)).6 
More recently, Clark has shown that substrates capable of chelation can be used to facilitate 
CEL of specific substrates (Scheme 1a (iii)).7 Herein we report a simple set of general 
reaction conditions that promote the efficient CEL reaction of aryl BPin esters and aryl 
amines (Scheme 1b). These conditions also operate effectively for the coupling of alkyl 
amines, providing the first set of general conditions for this previously troublesome process. 
 
  
Scheme 1. Approaches to Chan-Evans-Lam coupling of RBPin. 
 
Our initial investigation of the aryl amine/aryl BPin coupling was performed using a 
benchmark reaction between aniline (1a) and biphenyl BPin (2a) (Table 1). We began with 
standard CEL conditions (entry 1) to establish a general reactivity profile for this process, 
which gave 16% yield of the desired amine product 3a, highlighting the problem with these 
substrates. In addition to 3a, we observed the expected by-product of this reaction, phenol 4 
(1%). Conversion to product almost doubled when heating under reflux in CH2Cl2 (entry 2). 
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Table 1. Reaction optimization.a 
 
entry reaction conditions 3a:4:5:6 (%)b 
1 CH2Cl2, 0.25 M, 25 °C 16:1:0:-- 
2 CH2Cl2, 0.25 M, 40 °C 31:2:5:-- 
3 MeCN, 0.25 M, 60 °C 39:8:6:-- 
4 MeCN, 0.25 M, 80 °C 44:14:11:-- 
5 MeCN, 0.25 M, 3 Å MS, 80 °C 58:6:3:-- 
6 MeCN, 1.0 M, 3 Å MS, 80 °C 71:2:0:-- 
7 EtOH, 0.25 M, 60 °C 43:12:15:38 
8 MeCN:EtOH (20:1), 1.0 M, 3 Å MS, 80 °C 82:6:3:7 
9 MeCN:EtOH (20:1), 1.0 M, 3 Å MS, O2, 80 °Cc 21:2:0:0 
a 1a (1.0 equiv, 0.3 mmol), 2a (2 equiv, 0.6 mmol), Cu(OAc)2 (1 equiv, 0.3 mmol), Et3N (2 
equiv, 0.6 mmol), solvent, air, 24 h. b Determined by HPLC analysis using an internal 
standard. Mass balance is returned starting material. c Using 10 mol % Cu(OAc)2. 
 
A survey of reaction solvents was useful (a broad range of solvents was evaluated, see ESI). 
Replacement of CH2Cl2 with MeCN allowed access to higher reaction temperatures and 
provided a small increase in conversion to 3a with increases in formation of 4 and the 
emergence of 5, the product of protodeboronation, also noted (entries 3 and 4). Addition of 
molecular sieves reduced the levels of phenolic by-product 4 (entry 5) and increasing the 
reaction concentration boosted the yield of 3a further, providing relatively good efficiency 
(entry 6). In addition to lowering production of phenol by-product 4, removal of H2O by 
addition of molecular sieves was observed to decrease formation of protodeboronation by-


















to a significant quantity of the corresponding ether product 6 as expected;3a,b,4d,e,9 however, a 
competitive quantity of 3a was produced and, more importantly, complete conversion of 1a 
was observed for the first time (entry 7). This increase in reactivity may be attributable to an 
increase in mono-nuclear Cu(OAc)2 from the paddlewheel dimer, [Cu(OAc)2]2.10 To limit the 
production of 6 while attempting to retain this increase in reactivity, mixtures of MeCN:EtOH 
were evaluated (see ESI). At 20:1 MeCN:EtOH, the formation of 6 was lowered significantly 
and this provided an efficient system for the coupling of 1a and 2a (entry 8). Unfortunately, 
attempts to render the process catalytic were unsuccessful – using 10 mol % Cu(OAc)2 under 
an O2 atmosphere led to only 21% conversion to 3a (entry 9).  
 
The reason for the lack of efficiency under catalytic reaction conditions was intriguing since 
several literature methods report moderate to good efficiency using catalytic Cu(OAc)2 under 
an O2 atmosphere.11 In this regard, a series of control experiments using boronic acid 1b, 















Table 2. The inhibitory effect of pinacol on CEL reactions of boronic acid 1b.a 
 
entry pinacol time 3a (%)b 
1 --- 6 h 41 
2 --- 24 h 70 
3 1 equiv added at 0 h 6 h 11 
4 1 equiv added at 0 h 24 h 12 
5 1 equiv added at 6 h 6 h 46 
6 1 equiv added at 6 h 24 h 50 
 a 1b (1.0 equiv, 0.25 mmol), 2a (2 equiv, 0.5 mmol), Cu(OAc)2 (1 equiv, 0.25 mmol), Et3N 
(2 equiv, 0.5 mmol), CH2Cl2 (1 mL), air, 20 °C. b Determined by HPLC analysis using an 
internal standard.  
 
The CEL reaction of 1b with 2a proceeds well in the absence of pinacol, as expected (entries 
1 and 2). However, addition of stoichiometric pinacol at various time points immediately 
impedes the reaction. Specifically, addition of pinacol at t = 0 h leads to ca. 10% conversion 
over 6 h and this does not improve over an additional 18 h of reaction time (entries 3 and 4). 
Similarly, addition of pinacol at t = 6 h immediately halts the reaction at ca. 50% conversion 
(entries 5 and 6). The origin of this effect is unclear; however, diols are known to form stable 
complexes with Cu(II).12 We therefore speculate that pinacol, released as a by-product as the 
reactions of BPin substrates progress, inhibits catalyst turnover and therefore reaction 
efficiency. Accordingly, stoichiometric Cu(OAc)2 are required with BPin substrates. 
 
 
3 Å MS, CH2Cl2, 20 °C








Cu(OAc)2 (1 equiv), Et3N (2 equiv)
Based on this, we proceeded to evaluate the generality of the optimum stoichiometric 
conditions (entry 8). Application of the developed protocol to a range of ArBPin and aniline 
substrates showed the conditions to be broadly applicable (Scheme 2).  
 
Scheme 2. Scope of the developed CEL reaction conditions to a range of aryl BPin and aryl 
amine substrates. Isolated yields. 
The reaction conditions tolerated functionality on both the aryl BPin and aryl amine 
components. Electron-rich (3c, 3h, 3j), -neutral (3a, 3b, 3l), and –withdrawing groups (3d-g, 
3i, 3k) were tolerated on the ArBPin. The aryl amine was also broadly tolerant of 
functionality and substitution (3m-x). Yields were generally >70% with some diminished 
yields observed with specific components, in particular heterocycles (3u, 3w) and secondary 
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Pleasingly, the developed conditions were also found to be applicable to alkyl amines 
(Scheme 3). In this case, the addition of EtOH was not necessary to achieve good levels of 
reaction efficiency. Once more, a good diversity of BPin (7a-o) and amine (7p-7al) 
components was tolerated. Similar trends were observed with some heterocyclic (7l) and 
secondary amines (7p) delivering lower yields. While the product 7ah was isolated in 
relatively low yield due to competing arylation of the lactam, the reaction of other amides and 
carbamates were more chemoselective (e.g., 7i, 7m, 7aj). Taking the combined scope of aryl 
and alkyl amine, the developed reaction conditions allow the effective and general Chan-
Evans-Lam amination of aryl BPin.  
  
Scheme 3. Scope of the developed CEL reaction conditions to a range of aryl BPin and alkyl 
amine substrates. Isolated yields. 
Conclusions 
In summary, a straightforward set of reaction conditions has been developed that allow the 
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suitable for the coupling of alkyl amines. This provides the first general set of reaction 
conditions for the CEL reaction of aryl BPin reagents. 
 
Experimental Section 
General information. All reagents and solvents were obtained from commercial suppliers 
and were used without further purification unless otherwise stated. Purification was carried 
out according to standard laboratory methods. EtOAc and petroleum ether 40-60° for 
purification purposes were used as obtained from suppliers without further purification.  
Reactions were carried out using capped 5 mL microwave vials (reactions for Table 1, 
Scheme 2, and Scheme 3). Glassware was oven-dried (150 °C) and purged with N2 before use. 
Purging refers to a vacuum/nitrogen-refilling procedure. Room temperature was generally ca. 
20 °C. Reactions were carried out at elevated temperatures using a temperature-regulated 
hotplate/stirrer. 3 Å molecular sieves were purchased from Aldrich Chemical Company in 
powdered form, and activated and stored in a oven at 150 °C until their use. 
Purification and Analysis. Thin layer chromatography was carried out using silica plates 
coated with fluorescent indicator UV254. These were analyzed under 254 nm UV light or 
developed using potassium permanganate solution. 19F NMR spectra were obtained at 282 
MHz. 1H and 13C NMR spectra were obtained at 400 MHz and 101 MHz, respectively. 
Chemical shifts are reported in ppm and coupling constants are reported in Hz with CDCl3 
referenced at 7.27 ppm (1H) and 77.36 ppm (13C) and DMSO-d6 referenced at 2.50 ppm (1H) 
and 39.52 ppm (13C). High-resolution mass spectra were obtained using a quadropole time-of-
flight (Q-TOF) machine with electrospray ionization. Reverse phase HPLC data were 
obtained using a C18 column. Analysis was performed using a gradient method, eluting with 
5–80% MeCN/H2O over 16 minutes at a flow rate of 2 mL/min. Samples for HPLC analysis 
were prepared through the addition of 2 mL of caffeine standard to the reaction mixture. The 
resulting solution was then stirred before the removal of a 200 µL aliquot. The aliquot was 
diluted to 1 mL with MeCN. A 200 µL aliquot of the diluted solution was then filtered and 
further diluted with 800 µL MeCN and 500 µL H2O for HPLC analysis against established 
conversion factors. 
 
General procedure for the Chan–Evans–Lam amination of boronic acid pinacol (BPin) 
esters with aryl amines. A solution of aryl BPin (1 equiv, 0.30 mmol, 1 M), aryl amine (2 
equiv, 0.60 mmol), Cu(OAc)2 (1 equiv, 0.30 mmol, 54 mg), Et3N (2 equiv, 0.60 mmol, 61 mg, 
84 µL), and powdered activated 3 Å molecular sieves in MeCN-EtOH (20:1 ratio, 300 µL) 
was sealed into an oven dried round-bottomed 5 mL microwave vial under air and stirred at 
80 °C (preheated sand bath, sand temperature) for 24 h. The reaction mixture was allowed to 
cool to room temperature, filtered through Celite, and the filtrate was evaporated to give a 
residue that was purified by silica chromatography (EtOAc/petroleum ether with 1% Et3N 
modifier). Appropriate fractions were evaporated to afford the desired product. 
 
General procedure for the Chan–Evans–Lam amination of boronic acid pinacol (BPin) 
esters with alkyl amines. A solution of aryl BPin (1 equiv, 0.20 mmol, 0.5 M), alkyl amine 
(2 equiv, 0.40 mmol), Cu(OAc)2 (1 equiv, 0.20 mmol, 36 mg), Et3N (2 equiv, 0.40 mmol, 41 
mg, 56` µL), and powdered activated 3 Å molecular sieves in MeCN (400 µL) was sealed in 
an oven dried round-bottomed 5 mL microwave vial under air and stirred at 80 °C (preheated 
sand bath, sand temperature) for 24 h. The reaction mixture was allowed to cool to room 
temperature, filtered through Celite, and the filtrate was evaporated to give a residue that was 
purified by silica chromatography (EtOAc/petroleum ether with 1% Et3N modifier). 
Appropriate fractions were evaporated to afford the desired product. 
N-Phenyl-[1,1'-biphenyl]-4-amine (3a).13 Orange solid (57 mg, 79% yield). Purification: 
silica chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 110-111 °C. 1H 
NMR (400 MHz; DMSO-d6): δ 6.86 (t, J = 7.3 Hz, 1H), 7.12-7.17 (m, 4H), 7.27-7.28 (m, 3H), 
7.42 (t, J = 7.6 Hz, 2H), 7.55-7.63 (m, 4H), 8.30 (br. s., 1H). 13C NMR (101 MHz, DMSO-
d6): δ 117.2, 117.6, 119.6, 120.4, 126.2, 126.8, 127.8, 129.3, 129.7, 131.6, 140.5, 143.5. 
LCMS (ESI): tR = 1.43 min, [M+H]+ 246.2. HRMS (ESI): (C18H16N) [M+H]+ requires 
246.1277, found [M+H]+ 246.1279. υmax (neat): 3372, 1596, 1523, 1505, 1485, 1323, 846, 
759, 745, 693 cm-1.  
 
Diphenylamine (3b).14 White solid (38 mg, 74% yield). Purification: silica chromatography, 
0-3% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 51-52 °C. 1H NMR (400 MHz, DMSO-d6): 
δ 6.81 (t, J = 7.3 Hz, 2H), 7.05-7.07 (m, 4H), 7.20-7.24 (m, 4H), 8.10 (s, 1H). 13C NMR (101 
MHz, DMSO-d6): δ 116.7, 119.6, 129.1, 143.4. LCMS (ESI): tR = 1.21 min, [M+H]+ 170.2. 
HRMS (ESI): (C12H12N) [M+H]+ requires 170.0964, found [M+H]+ 170.0965. υmax (neat): 
3407, 3383, 3042, 1595, 1519, 1494, 1458, 1418, 1316, 1242, 1172, 876, 743, 689 cm-1. 
 
4-Methoxy-N-phenylaniline (3c).15 Yellow solid (42 mg, 70% yield). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 104-105 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 3.71 (s, 3H), 6.70 (t, J = 7.3 Hz, 1H), 6.85-6.92 (m, 4H), 7.03-7.05 
(m, 2H), 7.13-7.15 (m, 2H), 7.79 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 55.2, 114.5, 
114.8, 118.2, 120.3, 129.0, 136.1, 145.1, 153.8. LCMS (ESI): tR=1.17 min, [M+H]+ 200.3. 
HRMS (ESI): (C13H14NO) [M+H]+ requires 200.1070, found [M+H]+ 200.1073. υmax (neat): 
3388, 1596, 1501, 1443, 1316, 1298, 1249, 1181, 1033, 812, 750, 695 cm-1. 
 
Methyl-4-(phenylamino)benzoate (3d).16 White solid (54 mg, 78% yield). Purification: silica 
chromatography, 0-10% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 108-109 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 3.78 (s, 3H), 6.99 (t, J = 7.3 Hz, 1H), 7.05-7.07 (m, 2H), 7.17-7.20 
(m, 2H), 7.30-7.34 (m, 2H), 7.78-7.82 (m, 2H), 8.74 (s, 1H). 13C NMR (101 MHz, DMSO-
d6): δ 51.4, 113.9, 119.0, 119.4, 121.9, 129.2, 131.0, 141.2, 148.5, 165.9. LCMS (ESI): tR = 
1.17 min, [M+H]+ 228.2. HRMS (ESI): (C14H14NO2) [M+H]+ requires 228.1019, found 
[M+H]+ 228.1023. υmax (neat): 3334, 1687, 1589, 1532, 1496, 1433, 1344, 1281, 1251, 1172, 
1109, 851, 767, 747, 692 cm-1. 
 
4-Bromo-N-phenylaniline (3e).17 White solid (60 mg, 81% yield). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 88-89 °C. 1H NMR (400 
MHz, DMSO-d6): δ 6.87 (t, J = 7.5 Hz, 1H), 6.99-7.01 (m, 2H), 7.06-7.08 (m, 2H), 7.23-7.27 
(m, 2H), 7.34-7.37 (m, 2H), 8.27 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 110.0, 117.4, 
118.0, 120.3, 129.2, 131.7, 142.6, 143.0. LCMS (ESI): tR = 1.34 min, [M+H]+ 250.1. HRMS 
(ESI): (C12H11BrN) [M+H]+ requires 248.0069, found [M+H]+ 248.0076. υmax (neat): 3401, 
1579, 1500, 1481, 1312, 1070, 803, 748, 704, 690 cm-1. 
 
4-Chloro-N-phenylaniline (3f).17 Colourless solid (48 mg, 78% yield). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 65-66 °C. 1H NMR (400 
MHz, DMSO-d6): δ 6.86 (t, J = 7.2 Hz, 1H), 7.04-7.08 (m, 4H), 7.23-7.27 (m, 4 H), 8.25 (s, 
1H). 13C NMR (101 MHz, DMSO-d6): δ 117.2, 117.7, 120.2, 122.5, 128.9, 129.2, 142.5, 
142.7. LCMS (ESI): tR = 1.32 min, [M+H]+ 204.2. HRMS (ESI): (C12H11ClN) [M+H]+ 
requires 204.0575, found [M+H]+ 204.0579. υmax (neat): 3402, 1585, 1500, 1482, 1443, 1394, 
1307, 1298, 1171, 1069, 874, 804, 749, 710, 690 cm-1. 
 
3-(Phenylamino)benzonitrile (3g).18 Colourless solid (49 mg, 84% yield). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 95-96 °C. 1H NMR (400 
MHz, DMSO-d6): δ 6.95 (t, J = 7.4 Hz, 1H), 7.12-7.14 (m, 2H), 7.15-7.19 (m, 1H),  7.28-7.32 
(m, 4H), 7.33-7.39 (m, 1H), 8.52 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 111.9, 117.6, 
118.3, 119.1, 120.2, 121.4, 122.2, 129.3, 130.4, 141.7, 144.7. LCMS (ESI): tR = 1.15 min, 
[M+H]+ 195.2. HRMS (ESI): (C13H11N2) [M+H]+ requires 195.0917, found [M+H]+ 195.0921. 
υmax (neat): 3338, 2233, 1592, 1533, 1495, 1482, 1416, 1338, 1303, 1153, 993, 962.1, 863, 
778, 763, 711, 695, 677 cm-1. 
 
tert-Butyl-(3-(phenylamino)phenyl)carbamate (3h). Colourless solid (57 mg, 67% yield). 
Purification: silica chromatography, 0-10% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 87–
88 °C. 1H NMR (400 MHz, DMSO-d6): δ 1.47 (s, 9H), 6.67 (t, J = 7.1 Hz, 1H), 6.80 (m, 1H), 
6.90 (m, 1H), 7.04-7.07 (m, 3H), 7.19-7.23 (m, 2H), 7.32 (s, 1H), 8.08 (s, 1H), 9.18 (s, 1H). 
13C NMR (101 MHz, DMSO-d6): δ 28.1, 78.7, 106.6, 109.9, 110.7, 116.7, 119.4, 129.0, 140.3, 
143.4, 143.6, 152.7 (1 signal not observed). LCMS (ESI): tR = 1.29 min, [M+H]+ 285.2. 
HRMS (ESI): (C17H21N2O2) [M+H]+ requires 285.1598, found [M+H]+ 285.1604. υmax (neat): 
3331, 1692, 1595, 1526, 1497, 1450, 1398, 1368, 1275, 1247, 1153, 1053, 859, 761, 696 cm-1. 
 
N-Phenyl-3-(trifluoromethyl)aniline (3i).18 Colourless oil (53 mg, 74% yield). Purification: 
silica chromatography, 0-5% (EtOAc + 1% Et3N)/petroleum ether. 1H NMR (400 MHz, 
DMSO-d6): δ 6.93 (t, J = 7.3 Hz, 1H), 7.07-7.14 (m, 3H), 7.27-7.32 (m, 4H), 7.40-7.42 (m, 
1H), 8.51 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 111.5 (q, JC-F = 4.2 Hz), 115.0 (q, JC-F = 
4.2 Hz), 118.2, 118.9 (q, JC-F = 1 Hz), 121.2, 125.6 (q, JC-F = 273 Hz), 129.5, 129.8, 130.4 (q, 
JC-F = 35 Hz), 142.0, 144.7. 19F-NMR (282 MHz, DMSO-d6): δ -61.5 (s). LCMS (ESI): tR = 
1.34 min, [M+H]+ 238.2. HRMS (ESI): (C13H11F3N) [M+H]+ requires 238.0838, found 
[M+H]+ 238.0841. υmax (neat): 3404, 1658, 1049, 1023, 999, 824, 761 cm-1. 
 
3-Methyl-N-phenylaniline (3j).18 Yellow oil (30 mg, 55%). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. 1H NMR (400 MHz, DMSO-d6): 
δ 2.19 (s, 3H), 6.74 (t, J = 7.5 Hz, 1H), 6.86-6.91 (m, 3H), 7.10-7.19 (m, 5H), 7.33 (s, 1H). 
13C NMR (101 MHz, DMSO-d6): δ 17.9, 116.0, 118.7, 119.7 121.8, 126.4, 128.9, 129.4, 
130.8, 141.3, 145.0. LCMS (ESI): tR = 1.29 min, [M+H]+ 184.2. HRMS (ESI): (C13H14N) 
[M+H]+ requires 184.1121 , found [M+H]+ 184.1123. υmax (neat): 3407, 3383, 3042, 1595, 
1519, 1494, 1458, 1418, 1318, 1242, 1172, 1083, 1023, 993, 876, 846 cm-1. 
 
2-Fluoro-5-(phenylamino)benzonitrile (3k). Colourless solid (37 mg, 58% yield). 
Purification: silica chromatography, 0-10% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 90– 
91 °C. 1H NMR (400 MHz, DMSO-d6): δ 6.93 (t, J = 7.3 Hz, 1H), 7.07-7.10 (m, 2H), 7.26-
7.30 (m, 2H), 7.35-7.37 (m, 3H), 8.43 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 100.1 (d, 
JC-F = 2.8 Hz), 114.2, 117.3 (d, JC-F = 24 Hz), 117.6, 119.5 (d, JC-F = 253 Hz), 123.3 (d, JC-F = 
8 Hz), 129.3, 141.1, 142.1, 154.7, 157.2. 19F-NMR (282 MHz, DMSO-d6): δ -121.2 (s). 
LCMS (ESI): tR = 1.18 min, [M+H]+ 213.2. HRMS (ESI): (C13H10FN2) [M+H]+ requires 
213.0828, found [M+H]+ 213.0823. υmax (neat): 3345, 3039, 2243, 1595, 1533, 1493, 1402, 
1348, 1241, 1226, 1171, 818, 755, 718, 693 cm-1. 
 
N-Phenylnaphthalen-2-amine (3l).19 Colourless solid (51 mg, 77% yield). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 107–108 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 6.89 (t, J = 7.2 Hz, 1H), 7.18-7.21 (m, 6H), 7.26-7.29 (m, 1H), 7.45 
(d, J = 8.3 Hz 1H), 7.66 (d, J = 8.1 Hz 1H), 7.73-7.78 (m, 2H), 8.38 (s, 1H). 13C NMR (101 
MHz, DMSO-d6): δ 108.9, 117.3, 119.9, 120.1, 122.7, 126.1, 126.2, 127.3, 128.1, 128.7, 
129.2, 134.3, 141.3, 143.0. LCMS (ESI): tR = 1.35 min, [M+H]+ 220.2. HRMS (ESI): 
(C16H14N) [M+H]+ requires 220.1121, found [M+H]+ 220.1127. υmax (neat): 3401, 1596, 1496, 
1304, 854, 737, 690 cm-1. 
 
N-Methyl-N-phenylaniline (3m).20 Colourless oil (36 mg, 65% yield). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether.1H NMR (400 MHz, DMSO-d6): 
δ 3.25 (s, 3H), 6.94 (t, J = 7.2 Hz, 2H), 6.97-7.00 (m, 4H), 7.25-7.29 (m, 4H). 13C NMR (101 
MHz, DMSO-d6): δ 120.0, 121.1, 129.1, 148.6 (one signal obscured by DMSO signals). 
LCMS (ESI): tR = 1.36 min, [M+H]+ 184.2. HRMS (ESI): (C13H14N) [M+H]+ requires 
184.1121, found [M+H]+ 184.1123. υmax (neat): 3036, 1584, 1493, 1340, 1271, 1251, 1185, 
1156, 1130, 1091, 1074, 1023, 991, 864, 747, 722, 690 cm-1. 
 
N-Isopropyl-N-phenylaniline (3n).21 Colourless oil (15 mg, 24% yield). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. 1H NMR (400 MHz, DMSO-d6): 
δ 1.07 (d, J = 4.1 Hz, 6H), 4.30 (sept, J = 2.3 Hz, 1H), 6.78-6.81 (m, 4H), 6.94-6.98 (t, J = 7.5 
Hz, 2H), 7.24-7.28 (m, 4H). 13C NMR (101 MHz, DMSO-d6): δ 21.4, 48.3, 122.0, 123.1, 
129.8, 146.8. LCMS (ESI): tR = 1.52 min, [M+H]+ 212.2. HRMS (ESI): (C15H18N) [M+H]+ 
requires 212.1434, found [M+H]+ 212.1425. υmax (neat): 3042, 1586, 1498, 1340, 1242, 1183, 
1132, 1092, 1088, 993, 880, 777, 710, 690 cm-1. 
 
Methyl-4-(phenylamino)benzoate (3o).15 White solid (54 mg, 69% yield). Purification: silica 
chromatography, 0-10% (EtOAc + 1% Et3N)/petroleum ether.M.pt.: 108-109 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 3.78 (s, 3H), 6.99 (t, J = 7.3 Hz, 1H), 7.05-7.07 (m, 2H), 7.17-7.20 
(m, 2H), 7.30-7.34 (m, 2H), 7.78-7.82 (m, 2H),  8.74 (s, 1H). 13C NMR (101 MHz, DMSO-
d6): δ 51.4, 113.9, 119.0, 119.4, 121.9, 129.2, 131.0, 141.2, 148.5, 165.9. LCMS (ESI): tR = 
1.17 min, [M+H]+ 228.2. HRMS (ESI): (C14H14NO2) [M+H]+ requires 228.1019, found 
[M+H]+ 228.1023. υmax (neat): 3334, 1687,1589, 1532, 1496, 1433, 1344, 1281, 1251, 1172, 
1109, 851, 767, 747, 692 cm-1. 
 
4-Methoxy-N-phenylaniline (3p).16 Yellow solid (52 mg, 87% yield). M.pt.: 104-105 °C. 
Purification: silica chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. 1H NMR 
(400 MHz, DMSO-d6): δ 3.71 (s, 3H), 6.69 (t, J = 7.3 Hz, 1H), 6.85-6.92 (m, 4H), 7.03-7.05 
(m, 2H), 7.13-7.15 (m, 2H), 7.79 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 55.2, 114.5, 
114.8, 118.2, 120.3, 129.0, 136.1, 145.1, 153.8. LCMS (ESI): tR = 1.17 min, [M+H]+ 200.3. 
HRMS (ESI): (C13H14NO) [M+H]+ requires 200.1070, found [M+H]+ 200.1073. υmax (neat): 
3388, 1596, 1501, 1443, 1316, 1298, 1249, 1181, 1033, 812, 750, 695 cm-1. 
 
4-Bromo-N-phenylaniline (3q).17 White solid (53 mg, 71% yield). M.pt.: 88-89 °C. 
Purification: silica chromatography, 0-3% (EtOAc + 1% Et3N)/petroleum ether. 1H NMR 
(400 MHz, DMSO-d6): δ 6.87 (t, J = 7.5 Hz, 1H), 6.99-7.01 (m, 2H), 7.06-7.08 (m, 2H), 7.23-
7.27 (m, 2H), 7.34-7.36 (m, 2H),  8.27 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 110.0, 
117.4, 118.0, 120.3, 129.2, 131.7, 142.6, 143.0. LCMS (ESI): tR = 1.34 min, [M+H]+ 250.1. 
HRMS (ESI): (C12H11BrN) [M+H]+ requires 248.0069, found [M+H]+ 248.0076. υmax (neat): 
3401, 1579, 1500, 1481, 1312, 1070, 803, 748, 704, 690 cm-1. 
 
3-(Phenylamino)benzoic acid (3r).22 White solid (53 mg, 83% yield). Purification: silica 
chromatography, 0-30% (EtOAc + 1% AcOH)/petroleum ether. M.pt.: 140-141 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 6.88 (t, J = 7.1 Hz, 1H), 7.09-7.11 (m, 2H), 7.27-7.33 (m, 5H), 7.65 
(s, 1H), 8.33 (s, 1H), 12.81 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 116.5, 117.5, 120.1, 
120.2, 120.4, 129.2, 129.3, 131.7, 142.7, 143.9, 167.4. LCMS (ESI): tR = 1.01 min, [M+H]+ 
214.2. HRMS (ESI): (C13H12NO2) [M+H]+ requires 214.0863, found [M+H]+ 214.0865. υmax 
(neat): 3407, 2989, 1686, 1593, 1512, 1463, 1427, 1296, 1279, 996, 934, 882, 786, 749, 698, 
681, 664 cm-1. 
 
4-Chloro-2-nitro-N-phenylaniline (3s). Red solid (39 mg, 52% yield). Purification: silica 
chromatography, 0-15% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 59-61 °C. 1H NMR (400 
MHz, DMSO-d6): δ 7.16-7-23 (m, 2H), 7.31-7.33 (m, 2H), 7.41-7.43 (m, 2H), 7.48-7.52 (m, 
1H), 8.12 (s, 1H), 9.40 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 118.7, 120.8, 124.0, 125.0, 
125.2, 129.5, 133.4, 135.6, 138.9, 141.0. LCMS (ESI): tR = 1.38 min, [M+H]+ 249.1. HRMS 
(ESI): (C12H10ClN2O2) [M+H]+ requires 249.0425, found [M+H]+ 249.0432. υmax (neat): 3338, 
1618, 1593, 1566, 1526, 1498, 1456, 1407, 1345, 1246, 1213, 1148, 1074, 902, 885, 849, 819, 
766, 759, 725, 694, 667 cm-1. 
 
2-(Phenylamino)-5-(trifluoromethyl)benzoic acid (3t). White solid (36 mg, 43% yield). 
Purification: silica chromatography, 0-25% (EtOAc + 1% AcOH)/petroleum ether. M.pt.: 77-
78 °C. 1H NMR (400 MHz, DMSO-d6): δ 7.20-7.23 (m, 2H), 7.32-7.33 (m, 2H), 7.41-7.45 (m, 
2H), 7.64-7.67 (m, 1H), 8.14 (s, 1H), 9.97 (s, 1H), 13.57 (s, 1H). 13C NMR (101 MHz, 
DMSO-d6): δ 111.5, 113.7, 116.7 (q, JC-F = 24 Hz), 123.1, 124.7, 125.7, 129.6, 130.3(dt, JC-F 
= 168 Hz, 7.3 Hz), 139.0, 150.1, 168.9 (1 signal not observed). 19F-NMR (282 MHz, DMSO-
d6): δ -60.1 (s). LCMS (ESI): tR = 1.41 min, [M+H]+ 282. HRMS (ESI): (C14H11F3NO2) 
[M+H]+ requires 282.0736, found [M+H]+ 282.0739. υmax (neat): 3330, 2901, 1666, 1592, 
1577, 1524, 1499, 1435, 1417, 1321, 1243, 1139, 1068, 904, 823, 792, 758, 745, 682, 662 cm-
1. 
 
N-Phenylbenzo[b]thiophen-5-amine (3u). Grey solid (33 mg, 51% yield). Purification: silica 
chromatography, 0-10% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 120-121 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 6.81 (t, J = 7.3 Hz, 1H), 7.08-7.11 (m, 3H), 7.21-7.23 (m, 2H), 7.33 
(d, J = 6.3 Hz, 1H), 7.57 (d, J = 6.2 Hz, 1H), 6.67 (d, J = 6.7 Hz, 1H), 7.81 (d, J = 6.7 Hz, 
1H), 8.17 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 110.1, 116.3, 117.1, 119.4, 122.9, 123.6, 
127.7, 129.1, 130.9, 140.5, 143.9 (1 signal not observed). LCMS (ESI): tR = 1.33 min, 
[M+H]+ 226.1. HRMS (ESI): (C14H12NS) [M+H]+ requires 226.0685, found [M+H]+ 226.0686. 
υmax (neat): 3376, 3053, 1667, 1596, 1512, 1497, 1433, 1344, 1298, 1267, 1246, 1201, 1153, 
1086, 1049, 1028, 892, 861, 825, 802, 745, 712, 670 cm-1. 
 
N-Phenylpyridin-3-amine (3v).23 White solid (20 mg, 40% yield). Purification: silica 
chromatography, 0-50% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 140-141 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 6.72 (t, J = 7.2 Hz, 1H), 6.82-6.87 (m, 2H), 7.23-7.27 (m, 2H), 7.54 
(m, 1H), 7.67 (m, 2H), 8.15 (s, 1H), 8.96 (s, 1H). 13C NMR (101 MHz, DMSO-d6): δ 110.6, 
114.1, 117.9, 120.2, 128.5, 137.1, 141.7, 147.1, 155.8. LCMS (ESI): tR = 0.36 min, [M+H]+ 
171.2. HRMS (ESI): (C11H11N2) [M+H]+ requires 171.0917, found [M+H]+ 171.0915. υmax 
(neat): 3008, 1667, 1588, 1574, 1530, 1493, 1464, 1442, 1430, 1327, 1253, 1159, 1148, 1159, 
992, 768, 747, 695 cm-1. 
 
N-Phenylpyridin-2-amine (3w).24 White solid (17 mg, 34% yield). Purification: silica 
chromatography, 0-50% (EtOAc + 1% Et3N)/petroleum ether. M.pt.: 140-141 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 6.71 (t, J = 7.2 Hz, 1H), 6.81-6.87 (m, 2H), 7.23-7.27 (m, 2H), 7.54 
(t, J = 7.4 Hz, 1H), 7.66 (m, 2H), 8.14 (s, 1H), 8.95 (s, 1H). 13C NMR (101 MHz, DMSO-d6): 
δ 110.6, 114.1, 117.9, 120.2, 128.5, 137.1, 141.7, 147.1, 155.8. LCMS (ESI): tR = 0.36 min, 
[M+H]+ 171.2. HRMS (ESI): (C11H11N2) [M+H]+ requires 171.0917, found [M+H]+ 171.0915. 
υmax (neat): 3088, 1589, 1537, 1494, 1464, 1444, 1327, 992, 770, 748, 696 cm-1. 
 
4-(Indolin-1-yl)benzoic acid (3x). Grey solid (20 mg, 31% yield). Purification: silica 
chromatography, 0-40% (EtOAc + 1% AcOH)/petroleum ether. M.pt.: 139-140 °C. 1H NMR 
(400 MHz, DMSO-d6): δ 3.09 (t, J = 7.2 Hz, 2H), 3.94 (t, J = 7.7 Hz, 2H), 6.71-6.75 (m, 1H), 
7.13-7.15 (m, 1H), 7.16-7.19 (m, 4H), 7.85-7.88 (m, 2H) (1 signal not observed). 13C NMR 
(101 MHz, DMSO-d6): δ 27.4, 51.4, 108.1, 115.3, 118.8, 125.0, 126.9, 130.2, 131.4, 144.4, 
146.0, 169.1, 178.8. LCMS (ESI): tR = 1.15 min, [M+H]+ 240.1. HRMS (ESI): (C15H14NO2) 
[M+H]+ requires 240.1019, found [M]+ 240.1007. υmax (neat): 3341, 2861, 1684, 1594, 1568, 
1529, 1511, 1482, 1457, 1402, 1320, 1295, 1187, 1170, 928, 790, 740, 708 cm-1. 
 
1-([1,1'-Biphenyl]-4-yl)piperidine (7a).25 White solid (35 mg, 74% yield). Purification: silica 
chromatography, 0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.55-1.64 (m, 2H), 1.67-1.76 (m, 4H), 3.20 (t, J = 5.1 Hz, 4H), 6.98 (d, J = 8.8 Hz, 2H), 7.25-
7.27 (m, 1 H), 7.35-7.41 (m, 2H), 7.49 (d, J = 8.8 Hz, 2H) 7.54-7.56 (m, 2H). 13C NMR (101 
MHz, CDCl3): δ 24.4, 25.8, 50.4, 116.4, 126.3, 126.5, 127.6, 128.7, 131.6, 141.1, 151.4. 
LCMS (ESI): tR = 0.89 min, [M+H]+ 238.3. υmax (neat): 2934, 2814, 1604, 1525, 1488, 1448, 
1384, 1337, 1236, 1125, 917, 820, 760, 718, 691 cm-1. 
 
1-Phenylpiperidine (7b). Colourless oil (23 mg, 71% yield).26 Purification: silica 
chromatography, 0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.53-1.61 (m, 2H), 1.66-1.75 (m, 4H), 3.15 (t, J = 5.4 Hz, 4H), 6.78-6.84 (m, 1H), 6.93 (dd, J 
= 8.7, 0.9 Hz, 2H), 7.20-7.27 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 24.4, 25.9, 50.7, 116.5, 
119.1, 129.0, 152.3. LCMS (ESI): tR = 1.29 min, [M+H]+ 162.3. υmax (neat): 2932, 2853, 2805, 
1597, 1493, 1450, 1384, 1334, 1235, 1220, 1131, 1025, 993, 916, 859, 753, 690 cm-1.  
 
1-(4-Methoxyphenyl)piperidine (7c).26 Off-white gum (30 mg, 78% yield). Purification: silica 
chromatography, 0-1.5% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.50-1.58 (m, 2H), 1.67-1.75 (m, 4H), 3.02 (t, J = 5.4 Hz, 4H), 3.76 (s, 3H), 6.82 (d, J = 9.0 
Hz, 2H), 6.91 (d, J = 9.0 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 24.2, 26.2, 52.3, 55.6, 
114.4, 118.7, 147.0, 153.6. LCMS (ESI): tR = 1.21 min, [M+H]+ 121.3. υmax (neat): 2934, 
2802, 1510, 1453, 1243, 1182, 1121, 1041, 920, 823 cm-1. 
 
Methyl 4-(piperidin-1-yl)benzoate (7d).27 White solid (32 mg, 73% yield). Purification: silica 
chromatography, 0-1.5% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.59-1.72 (m, 6H), 3.32 (t, J = 4.6 Hz, 4H), 3.85 (s, 3H), 6.84 (d, J = 9.0 Hz, 2H), 7.89 (d, J = 
9.0 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 24.4, 25.4, 48.8, 51.5, 113.6, 118.7, 131.2, 154.5, 
167.2. LCMS (ESI): tR = 1.28 min, [M+H]+ 220.3. υmax (neat): 2847, 2843, 1704, 1606, 1516, 
1436, 1287, 1247, 1191, 1110, 964, 916, 827, 771, 694 cm-1.  
 
1-(4-Bromophenyl)piperidine (7e).28 White solid (41 mg, 85% yield). Purification: silica 
chromatography, 0-1.5% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.54-1.61 (m, 2H), 1.64-1.73 (m, 4H), 3.12 (t, J = 5.4 Hz, 4H), 6.79 (d, J = 9.0 Hz, 2H), 7.31 
(d, J = 9.0 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 24.2, 25.7, 50.4, 111.1, 118.0, 131.7, 
151.2. LCMS (ESI): tR = 1.46 min, [M+H]+ 240.2. υmax (neat): 2941, 2858, 2817, 1588, 1494, 
1450, 1387, 1340, 1280, 1243, 1223, 1127, 992, 917, 860, 808 cm-1. 
 
1-(4-Chlorophenyl)piperidine (7f).29 White solid (33 mg, 84% yield). Purification: silica 
chromatography, 0-1.5% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 67-69 °C. 1H NMR (400 
MHz, CDCl3): δ 1.51-1.61 (m, 2H), 1.65-1.74 (m, 4H), 3.11 (t, J = 5.4 Hz, 4H), 6.82-6.85(m, 
2H), 7.15-7.20 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 24.2, 25.7, 50.6, 117.6, 123.9, 128.8, 
150.8. LCMS (ESI): tR = 1.43 min, [M+H]+ 196.3. υmax (neat): 2940, 2810, 1596, 1492, 1441, 
1383, 1338, 1242, 1223, 1127, 993, 916, 858, 808, 747 cm-1.  
 
1-(3-Cyanophenyl)piperidine (7g).30 Off-white gum (24 mg, 64% yield). Purification: silica 
chromatography, 0-2.5% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.58-1.74 (m, 6H), 3.19 (t, J = 5.4 Hz, 4H), 7.03 (d, J = 7.3 Hz, 1H), 7.07-7.12 (m, 2H), 7.25-
7.31 (m, 1H). 13C NMR (101 MHz, CDCl3): δ 24.1, 25.4, 49.7, 112.9, 118.6, 119.5, 120.1, 
121.7, 129.7, 151.9. LCMS (ESI): tR = 1.25 min, [M+H]+ 187.3. υmax (neat): 2937, 2861, 2216, 
1595, 1572, 1493, 1438, 1383, 1247, 1123, 996, 955, 784, 688 cm-1. 
 
1-(4-(Trifluoromethoxy)phenyl)piperidine (7h). Colourless oil (35 mg, 71% yield). 
Purification: silica chromatography, 0-1% (EtOAc + 2% Et3N)/cyclohexane. 1H NMR (400 
MHz, CDCl3): δ 1.52-1.62 (m, 2H), 1.65-1.74 (m, 4H), 3.13 (t, J = 5.4 Hz, 4H), 6.88 (d, J = 
9.0 Hz, 2H), 7.08 (dd, J = 9.2, 0.9 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 24.2, 25.8, 50.7, 
116.9, 120.7 (q, JC-F = 255.3 Hz), 121.8, 141.6 (q, JC-F = 2.0 Hz), 151.0. 19F NMR (282 MHz, 
CDCl3): δ -58.32 (s). LCMS (ESI) tR = 1.48 min, [M+H]+ 246.3. HRMS (ESI): (C12H15F3NO) 
[M+H]+ requires 246.1100, found [M+H]+ 246.1101. υmax (neat): 2938, 1509, 1260, 1232, 
1206, 1155, 1131, 1026, 920, 835, 807 cm-1. 
 
N-Methyl-3-(piperidin-1-yl)benzamide (7i). Off-white solid (27 mg, 62% yield). Purification: 
silica chromatography, 0-35% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 96-98 °C. 1H NMR 
(400 MHz, CDCl3): δ 1.53-1.62 (m, 2H), 1.64-1.73 (m, 4H), 2.98 (d, J = 4.9 Hz, 3H), 3.19 (t, 
J = 5.1 Hz, 4H), 6.27 (br. s., 1H), 7.02 (ddd, J = 8.3, 2.7, 1.0 Hz, 1H), 7.05-7.10 (m, 1H), 7.24 
(t, J = 7.8 Hz, 1H), 7.35-7.39 (m, 1H). 13C NMR (101 MHz, CDCl3): δ 24.2, 25.7, 26.8, 50.3, 
114.9, 116.5, 119.0, 129.0, 135.6, 152.3, 168.8. LCMS (ESI): tR = 0.91 min, [M+H]+ 219.3. 
HRMS (ESI): (C13H19N2O) [M+H]+ requires 219.1492, found [M+H]+ 219.1492. υmax (neat): 
3315, 2934, 2854, 2806, 1636, 1598, 1576, 1543, 1489, 1443, 1365, 1343, 1239, 1127, 940, 
755, 693 cm-1.  
 
N,N-Dimethyl-3-(piperidin-1-yl)benzamide (7j). Off-white gum (38 mg, 82% yield). 
Purification: silica chromatography, 0-30% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 
MHz, CDCl3): δ 1.51-1.63 (m, 2H), 1.65-1.74 (m, 4H), 2.97 (br. s., 3H), 3.09 (br. s., 3H), 
3.17 (t, J = 5.6 Hz, 4H), 6.79 (dd, J = 7.5, 1.1 Hz, 1H), 6.91-6.97 (m, 2H), 7.20-7.25 (m, 1H). 
13C NMR (101 MHz, CDCl3): δ 24.3, 25.7, 35.2, 39.5, 50.3, 114.7, 117.2, 117.2, 128.9, 137.2, 
152.1, 172.2. LCMS (ESI): tR = 1.00 min, [M+H]+ 233.4. HRMS (ESI): (C14H21N2O) [M+H]+ 
requires 233.1648, found [M+H]+ 233.1648. υmax (neat): 2932, 2854, 1635, 1599, 1575, 1485, 
1444, 1389, 1267, 1244, 1096, 994, 911, 749 cm-1. 
 
1-(o-Tolyl)piperidine (7k).31 Off-white gum (14 mg, 40% yield). Purification: silica 
chromatography, 0-0.5% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.54-1.60 (m, 2H), 1.66-1.74 (m, 4H), 2.30 (s, 3H), 2.83 (t, J = 4.9 Hz, 4H), 6.94 (ddd, J = 7.3, 
1.0 Hz, 1H), 7.00 (d, J = 7.8 Hz, 1H), 7.11-7.18 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 
17.8, 24.5, 26.6, 53.4, 119.0, 122.6, 126.4, 130.9, 132.7, 153.0. LCMS (ESI): tR = 1.52 min, 
[M+H]+ 176.3. υmax (neat): 2933, 2852, 2801, 1599, 1491, 1451, 1442, 1379, 1326, 1227, 
1124, 1106, 1028, 923, 759, 723 cm-1. 
 
3-(Piperidin-1-yl)pyridine (7l).32 Brown gum (7 mg, 22% yield). Purification: silica 
chromatography, 0-75% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.55-1.65 (m, 2H), 1.67-1.76 (m, 4H), 3.19 (t, J = 5.4 Hz, 4H), 7.13 (ddd, J = 8.6, 4.6, 0.7 Hz, 
1H), 7.18 (ddd, J = 8.3, 2.7, 1.5 Hz, 1H), 8.05 (dd, J = 4.5, 1.3 Hz, 1H), 8.31 (d, J =2.7 Hz, 
1H). 13C NMR (101 MHz, CDCl3): δ 24.1, 25.6, 49.9, 122.6, 123.3, 139.0, 140.0, 147.7. 
LCMS (ESI): tR = 0.94 min, [M+H]+ 163.3. υmax (neat): 2935, 2854, 2810, 1582, 1488, 1451, 
1424, 1384, 1346, 1245, 1131, 919, 859, 797, 707 cm-1. 
 tert-Butyl (3-(piperidin-1-yl)phenyl)carbamate (7m). White solid (42 mg, 76% yield). 
Purification: silica chromatography, 0-5% (EtOAc + 1% Et3N)/cyclohexane.  M.pt.: 94-95 °C. 
1H NMR (400 MHz, CDCl3): δ 1.51 (s, 9 H), 1.53-1.60 (m, 2H), 1.68 (dt, J = 11.2, 5.6 Hz, 
4H), 3.14 (t, J = 5.6 Hz, 4H), 6.44 (br. s., 1H), 6.60 (dd, J = 8.2, 2.1 Hz, 1H), 6.68 (dd, J = 7.8, 
1.5 Hz, 1H), 7.08 (br. s., 1H), 7.09-7.14 (m, 1H). 13C NMR (101 MHz, CDCl3): δ 24.4, 25.8, 
28.4, 50.5, 80.2, 106.6, 109.3, 111.3, 129.3, 139.2, 152.7, 153.0. LCMS (ESI): tR = 1.36 min, 
[M+H]+ 277.3. HRMS (ESI): (C16H25N2O2) [M+H]+ requires 277.1911, found [M+H]+ 
277.1914. υmax (neat): 3328, 2933, 1698, 1607, 1532, 1497, 1443, 1366, 1236, 1155, 1053, 
1026, 979, 954, 901, 861, 768, 692 cm-1. 
 
4-(4-(Piperidin-1-yl)benzyl)morpholine (7n). Colourless oil (38 mg, 73% yield). Purification: 
silica chromatography, 0-45% (EtOAc + 2% Et3N)/cyclohexane. 1H NMR (400 MHz, 
CDCl3): δ 1.53-1.61 (m, 2H), 1.66-1.75 (m, 4H), 2.42 (t, J = 4.6 Hz, 4H), 3.14 (t, J = 5.1 Hz, 
4H), 3.41 (s, 2H), 3.69 (t, J = 4.9 Hz, 4H), 6.88 (d, J = 8.6 Hz, 2H), 7.17 (d, J = 8.6 Hz, 2H). 
13C NMR (101 MHz, CDCl3): δ 24.3, 25.9, 50.7, 53.6, 63.0, 67.1, 116.2, 128.0, 130.0, 151.4. 
LCMS (ESI): tR = 1.17 min, [M+H]+ 261.4. HRMS (ESI): (C16H25N2O) [M+H]+ requires 
261.1961, found [M+H]+ 261.1961. υmax (neat): 2932, 2853, 2804, 1613, 1515, 1453, 1237, 
1118, 1006, 915, 866 cm-1. 
 
tert-Butyl 5-(piperidin-1-yl)indoline-1-carboxylate (7o). Off-white solid (39 mg, 65% yield). 
Purification: silica chromatography, 0-7% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 88-91 °C. 
1H NMR (400 MHz, CDCl3): δ 1.51-1.56 (m, 2H), 1.55 (s, 9H), 1.66-1.76 (m, 4H), 2.98-3.08 
(m, 6H), 3.94 (br. s., 2H), 6.75 (d, J = 8.6 Hz, 1H), 6.80 (s, 1H), 7.35 (d, J = 8.0 Hz, 0.5H), 
7.74 (d, J = 8.2 Hz, 0.5H). 13C NMR (126 MHz, CDCl3): δ 24.2, 26.0, 27.3, 27.8, 28.5, 47.5, 
47.7, 52.2, 52.3, 80.0, 81.1, 114.7, 114.8, 114.9, 116.0, 116.4, 131.7, 132.7, 135.3, 136.4, 
148.3, 152.5, 152.8. LCMS (ESI): tR = 1.50 min, [M+H]+ 303.3. HRMS (ESI): (C18H27N2O2) 
[M+H]+ requires 303.2037, found [M+H]+ 303.2069. υmax (neat): 2932, 2855, 2793, 1692, 
1494, 1453, 1380, 1366, 1331, 1244, 1174, 1140, 1127, 1018, 950, 862, 813, 762 cm-1. 
 
N,N-Dibutylaniline (7p).33 Brown oil (4 mg, 10% yield).	Purification: silica chromatography, 
0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3) δ 0.95 (t, J = 7.3 Hz, 
6H), 1.29-1.40 (m, 4H), 1.52-1.62 (m, 4H), 3.22-3.29 (m, 4H), 6.58-6.67 (m, 3H), 7.15-7.22 
(m, 2H). LCMS (ESI): tR = 1.64 min, [M+H]+ 206.4. Matches data from Barker, T. J.; Jarvo, 
E. R. J. Am. Chem. Soc., 2009, 131, 15598–15599. 
 
N-Isopropylnaphthalen-2-amine (7q).34 Brown oil (27 mg, 73% yield). Purification: silica 
chromatography, 0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 1.26 
(d, J = 6.3 Hz, 6H), 3.58 (br. s., 1H), 3.75 (sept, J = 6.3 Hz, 1H), 6.78 (d, J = 2.4 Hz, 1H), 
6.82 (dd, J = 8.8, 2.4 Hz, 1H), 7.16 (ddd, J = 8.1, 6.9, 1.1 Hz, 1H), 7.33 (ddd, J = 8.3, 6.9, 1.2 
Hz, 1H), 7.59 (d, J = 8.1 Hz, 1H), 7.60 (d, J = 8.8 Hz, 1H), 7.64 (d, J = 8.1 Hz, 1H). 13C 
NMR (101 MHz, CDCl3): δ 22.9, 44.3, 105.0, 118.3, 121.8, 125.8, 126.2, 127.3, 127.6, 128.9, 
135.3, 145.1. LCMS (ESI): tR = 1.31 min, [M+H]+ 186.3. υmax (neat): 3403, 2966, 1627, 1603, 
1522, 1485, 1398, 1361, 1225, 1191, 828, 807, 744 cm-1. 
 
3-(Phenethylamino)benzonitrile (7r). Off-white solid (25 mg, 56% yield). Purification: silica 
chromatography, 0-3% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 61-63 °C. 1H NMR (400 
MHz, CDCl3): δ 2.92 (t, J = 7.0 Hz, 2H), 3.35-3.45 (m, 2H), 3.88 (br. s., 1H), 6.73-6.81 (m, 
2H), 6.95 (dt, J = 7.5, 1.1 Hz, 1H), 7.17-7.28 (m, 4H), 7.30-7.36 (m, 2H). 13C NMR (101 
MHz, CDCl3): δ 35.2, 44.6, 113.0, 115.0, 117.3, 119.4, 120.8, 126.7, 128.7, 128.8, 129.9, 
138.6, 148.2. LCMS (ESI): tR = 1.26 min, [M+H]+ 223.3. HRMS (ESI): (C15H15N2) [M+H]+ 
requires 223.1230, found [M+H]+ 223.1231. υmax (neat): 3392, 3028, 2930, 2857, 2227, 1602, 
1583, 1514, 1493, 1428, 1335, 1303, 780, 751, 700, 682 cm-1. 
 
2-Methyl-N-phenethylaniline (7s). Yellow gum (30 mg, 71% yield). Purification: silica 
chromatography, 0-1.5% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
2.02 (s, 3H), 2.96 (t, J = 6.8 Hz, 2H), 3.44 (t, J = 6.8 Hz, 2H), 3.51 (br. s., 1H), 6.62-6.70 (m, 
2H), 7.03 (d, J = 7.1 Hz, 1H), 7.09-7.16 (m, 1H), 7.20-7.27 (m, 3H), 7.28-7.35 (m, 2H). 13C 
NMR (101 MHz, CDCl3): δ 17.3, 35.5, 45.0, 109.9, 117.0, 122.1, 126.4, 127.1, 128.6, 128.8, 
130.1, 139.4, 145.9. LCMS (ESI): tR = 1.39 min, [M+H]+ 212.3. HRMS (ESI): (C15H18N) 
[M+H]+ requires 212.1434, found [M+H]+ 212.1435. υmax (neat): 3419, 3023, 2920, 2853, 
1606, 1587, 1514, 1473, 1453, 1317, 1263, 1130, 1052, 746, 700 cm-1. 
 
Methyl 1-phenylpiperidine-4-carboxylate (7t). Light yellow oil (27 mg, 62% yield). 
Purification: silica chromatography, 0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 
MHz, CDCl3): δ 1.81-1.93 (m, 2H), 1.97-2.07 (m, 2H), 2.45 (tt, J = 11.1, 4.0 Hz, 1H), 2.78 
(td, J = 11.9, 2.9 Hz, 2H), 3.64 (dt, J = 12.7, 3.3 Hz, 2H), 3.70 (s, 3H), 6.84 (t, J = 7.2 Hz, 
1H), 6.93 (d, J = 7.8 Hz, 2H), 7.21-7.28 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 28.1, 41.0, 
49.3, 51.7, 116.7, 119.7, 129.1, 151.6, 175.3. LCMS (ESI): tR = 1.15 min, [M+H]+ 220.3. 
HRMS (ESI): (C13H18NO2) [M+H]+ requires 220.1332, found [M+H]+ 220.1338. υmax (neat): 
2951, 2811, 1733, 1598, 1496, 1448, 1388, 1314, 1251, 1194, 1168, 1043, 922, 757, 694 cm-1. 
 
N,N-Dimethyl-1-phenylpiperidin-4-amine (7u). Yellow solid (28 mg, 69% yield). 
Purification: silica chromatography, 0-7% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 45-48 °C. 
1H NMR (400 MHz, CDCl3): δ 1.64 (qd, J = 12.1, 3.9 Hz, 2H), 1.89-1.97 (m, 2H), 2.24-2.31 
(m, 1H), 2.32 (s, 6H), 2.71 (td, J = 12.3, 2.6 Hz, 2H), 3.68-3.77 (m, 2H), 6.82 (t, J = 7.2 Hz, 
1H), 6.94 (dd, J = 8.7, 0.9 Hz, 2H), 7.20-7.28 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 28.3, 
41.7, 49.2, 62.2, 116.5, 119.4, 129.0, 151.5. LCMS (ESI): tR = 0.97 min, [M+H]+ 205.3. 
HRMS (ESI): (C13H21N2) [M+H]+ requires 205.1699, found [M+H]+ 205.1701. υmax (neat): 
2945, 2770, 1600, 1499, 1378, 1220, 1190, 1153, 1065, 1040, 994, 918, 757, 692 cm-1. 
 
4-Phenylthiomorpholine 1,1-dioxide (7v). White solid (23 mg, 54% yield). Purification: silica 
chromatography, 0-35% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 123-124 °C. 1H NMR (400 
MHz, CDCl3): δ 3.05-3.14 (m, 4H), 3.79-3.88 (m, 4H), 6.86-6.97 (m, 3H), 7.26-7.34 (m, 2H). 
13C NMR (101 MHz, CDCl3): δ 47.7, 50.6, 116.4, 120.9, 129.8, 147.7. LCMS (ESI): tR = 0.78 
min, [M+H]+ 212.3. HRMS (ESI): (C10H14NO2S) [M+H]+ requires 212.0740, found [M+H]+ 
212.0737. υmax (neat): 2930, 1598, 1498, 1309, 1384, 1276, 1227, 1176, 1121, 975, 858, 756, 
694 cm-1. 
 
4-Phenylmorpholine (7w).35 White solid (23 mg, 71% yield). Purification: silica 
chromatography, 0-2% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 54-55 °C. 1H NMR (400 
MHz, CDCl3): δ 3.16 (t, J = 4.9 Hz, 4H), 3.86 (t, J = 4.9 Hz, 4H), 6.85-6.94 (m, 3H), 7.26-
7.31 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 49.4, 67.0, 115.7, 120.0, 129.2, 151.3. LCMS 
(ESI): tR = 0.92 min, [M+H]+ 164.3. υmax (neat): 2953, 2844, 1603, 1501, 1453, 1331, 1263, 
1239, 1123, 1067, 925, 758, 695 cm-1.  
 
N-Butyl-N-methylaniline (7x).33 Off-white gum (14 mg, 43% yield). Purification: silica 
chromatography, 0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 0.94 
(t, J = 7.3 Hz, 3H), 1.29-1.40 (m, 2H), 1.49-1.60 (m, 2H), 2.91 (s, 3H), 3.30 (t, J = 7.3 Hz, 
2H), 6.63-6.72 (m, 3H), 7.18-7.26 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 14.0, 20.4, 28.9, 
38.3, 52.5, 112.1, 115.8, 129.2, 149.4. LCMS (ESI): tR = 1.42 min, [M+H]+ 164.3. υmax (neat): 
2958, 2869, 1600, 1507, 1366, 1207, 746, 691 cm-1. 
 
N-Methyl-N-(2-(methylsulfonyl)ethyl)aniline (7y). Colourless oil (18 mg, 42% yield). 
Purification: silica chromatography, 0-35% (EtOAc + 1% Et3N)/cyclohexane.1H NMR (400 
MHz, CDCl3): δ 2.91 (s, 3H), 2.98 (s, 3H), 3.25 (t, J = 6.8 Hz, 2H), 3.89 (t, J=7.0 Hz, 2H), 
6.76-6.84 (m, 3H), 7.25-7.31 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 38.8, 42.1, 46.7, 51.4, 
113.2, 118.2, 129.6, 148.1. LCMS (ESI): tR = 0.82 min, [M+H]+ 214.2. HRMS (ESI): 
(C10H16NO2S) [M+H]+ requires 214.0896, found [M+H]+ 214.0899. υmax (neat): 2927, 1600, 
1505, 1362, 1362, 1301, 1134, 955, 752, 695 cm-1. 
 
N-Butylaniline (7z).36 Colourless oil (21 mg, 70% yield). Purification: silica chromatography, 
0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 0.95 (t, J=7.3 Hz, 
3H), 1.37-1.48 (m, 2H), 1.55-1.64 (m, 2H), 3.10 (t, J = 7.1 Hz, 2H), 3.53 (br. s., 1H), 6.59 (d, 
J = 7.8 Hz, 2H), 6.67 (t, J = 7.3 Hz, 1H), 7.13-7.20 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 
13.9, 20.3, 31.7, 43.7, 112.7, 117.1, 129.2, 148.6. LCMS (ESI): tR = 1.26 min, [M+H]+ 150.3. 
υmax (neat): 3414, 2958, 2869, 1603, 1506, 1320, 1262, 1179, 747, 692 cm-1. 
 
N-Isopropylaniline (7aa).37 Off-white oil (14 mg, 52% yield). Purification: silica 
chromatography, 0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 1.20 
(d, J = 6.4 Hz, 6H), 3.37 (br. s., 1H), 3.62 (sept, J = 6.3 Hz, 1H), 6.58 (d, J = 7.6 Hz, 2H), 
6.66 (t, J = 7.3 Hz, 1H), 7.11-7.18 (m, 2 H). 13C NMR (101 MHz, CDCl3): δ 23.0, 44.2, 113.3, 
117.0, 129.3, 147.5. LCMS (ESI): tR = 1.12 min, [M+H]+ 136.2. υmax (neat): 3397, 2696, 1603, 
1506, 1317, 1256, 1179, 748, 693 cm-1. 
 
tert-Butyl 4-(2-(phenylamino)ethyl)piperidine-1-carboxylate (7ab). Off-white solid (50 mg, 
82% yield). Purification: silica chromatography, 0-10% (EtOAc + 1% Et3N)/cyclohexane. 
M.pt.: 92-94 °C. 1H NMR (400 MHz, CDCl3): δ 1.06-1.23 (m, 2H), 1.46 (s, 9H), 1.52-1.60 
(m, 3H), 1.69 (d, J = 13.0 Hz, 2H), 2.69 (t, J = 12.2 Hz, 2H), 3.14 (t, J = 7.0 Hz, 2H), 3.53 (br. 
s., 1H), 4.01-4.16 (m, 2H), 6.59 (dd, J = 8.6, 1.0 Hz, 2H), 6.69 (t, J = 7.3 Hz, 1H), 7.17 (dd, J 
= 8.4, 7.5 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 28.5, 32.2, 33.9, 36.3, 41.3, 44.0, 79.3, 
112.7, 117.3, 129.3, 148.4, 154.9. LCMS (ESI): tR = 1.39 min, [M+H]+ 305.3. HRMS (ESI): 
(C18H29N2O2) [M+H]+ requires 305.2224, found [M+H]+ 305.2231. υmax (neat): 3375, 2922, 
2850, 1675, 1602, 1507, 1423, 1365, 1278, 1244, 1166, 1143, 1090, 968, 866, 747, 693 cm-1. 
 
N-Cyclopentylaniline (7ac).38 Off-white gum (24 mg, 74% yield). Purification: silica 
chromatography, 0-1% (EtOAc + 1% Et3N)/cyclohexane.  1H NMR (400 MHz, CDCl3): δ 
1.40-1.53 (m, 2H), 1.55-1.78 (m, 4H), 1.95-2.08 (m, 2H), 3.61 (br. s., 1H), 3.73-3.82 (m, 1H), 
6.59 (dd, J = 8.6, 1.0 Hz, 2H), 6.66 (t, J = 7.3 Hz, 1H), 7.10-7.20 (m, 2H). 13C NMR (101 
MHz, CDCl3): δ 24.1, 33.6, 54.7, 113.2, 116.9, 129.2, 148.1. LCMS (ESI): tR = 1.27 min, 
[M+H]+ 162.3. υmax (neat): 3397, 2955, 2868, 1602,1504, 1429, 1313, 1180, 747, 692 cm-1. 
 
N-((Tetrahydro-2H-pyran-4-yl)methyl)aniline (7ad).39 Off-white oil (33 mg, 86% yield). 
Purification: silica chromatography, 0-9% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 
MHz, CDCl3): δ 1.30-1.43 (m, 2H), 1.66-1.75 (m, 2H), 1.78-1.91 (m, 1H), 3.03 (d, J = 6.6 Hz, 
2H), 3.39 (td, J = 11.8, 2.1 Hz, 2H), 3.71 (br. s., 1H), 3.94-4.03 (m, 2H), 6.60 (dd, J = 8.6, 1.0 
Hz, 2H), 6.66 - 6.72 (m, 1H), 7.13 - 7.20 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 31.1, 34.9, 
50.0, 67.8, 112.7, 117.3, 129.3, 148.3. LCMS (ESI): tR = 1.02 min, [M+H]+ 192.3. υmax (neat): 
3372, 2929, 2843, 1603, 1508, 1327, 1264, 1141, 1091, 1014, 984, 853, 749, 693 cm-1. 
 
N-Phenethylaniline (7ae).40 Off-white gum (34 mg, 86% yield). Purification: silica 
chromatography, 0-1.5% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
2.91 (t, J = 7.0 Hz, 2H), 3.40 (t, J = 7.0 Hz, 2H), 3.66 (br. s., 1H), 6.61 (dd, J = 8.6, 1.0 Hz, 
2H), 6.70 (tt, J = 7.3, 1.0 Hz, 1H), 7.14-7.26 (m, 5H), 7.28-7.34 (m, 2H). 13C NMR (101 MHz, 
CDCl3): δ 35.6, 45.1, 113.0, 117.5, 126.4, 128.6, 128.8, 129.3, 139.3, 148.0. LCMS (ESI): tR 
= 1.31 min, [M+H]+ 198.3. υmax (neat): 3409, 3025, 2928, 2861, 1602, 1506, 1454, 1319, 
1262, 1180, 748, 693 cm-1. 
 
N-(4-Methoxybenzyl)aniline (7af).41 Yellow oil (36 mg, 84% yield). Purification: silica 
chromatography, 0-2% (EtOAc + 1% Et3N)/cyclohexane.  1H NMR (400 MHz, CDCl3): δ 
3.80 (s, 3H), 3.92 (br. s., 1H), 4.25 (s, 2H), 6.63 (d, J = 7.8 Hz, 2H), 6.71 (t, J = 7.3 Hz, 1H), 
6.87 (d, J = 8.6 Hz, 2H), 7.14-7.20 (m, 2H), 7.28 (d, J = 8.6 Hz, 2H). 13C NMR (101 MHz, 
CDCl3): δ 47.8, 55.3, 112.9, 114.1, 117.5, 128.8, 129.2, 131.4, 148.2, 158.9. LCMS (ESI): tR 
= 1.22 min, [M-H]- 212.2. υmax (neat): 3416, 3011, 2927, 2835, 1603, 1509, 1465, 1431, 1302, 
1246, 1177, 1033, 824, 750, 693 cm-1. 
 
N-(4,4,4-Trifluorobutyl)aniline (7ag).39 Yellow oil (28 mg, 69% yield). Purification: silica 
chromatography, 0-1% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 
1.81-1.93 (m, 2H), 2.12-2.28 (m, 2H), 3.21 (t, J = 7.0 Hz, 2H), 3.59 (br. s., 1H), 6.60 (dd, J = 
8.7, 0.9 Hz, 2H), 6.68-6.76 (m, 1H), 7.13-7.22 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 22.2 
(q, JC-F = 2.7 Hz), 31.5 (q, JC-F = 28.6 Hz), 42.7, 112.8, 117.8, 127.1 (q, JC-F = 275.8 Hz), 
129.4, 147.8. 19F NMR (282 MHz, CDCl3): δ -66.14 (t, J=10.4 Hz, 3F). LCMS (ESI): tR = 
1.21 min, [M+H]+ 204.3. υmax (neat): 3414, 2948, 1604, 1508, 1391, 1316, 1295, 1250, 1225, 
1144, 1028, 750, 693 cm-1. 
 
4-((Phenylamino)methyl)pyrrolidin-2-one (7ah). Off-white solid (12 mg, 32% yield). 
Purification: silica chromatography, 0-100% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 95-
98 °C. 1H NMR (400 MHz, CDCl3): δ 2.16 (dd, J = 17.1, 6.1 Hz, 1H), 2.51 (dd, J = 16.9, 8.8 
Hz, 1H), 2.72-2.85 (m, 1H), 3.15-3.26 (m, 3H), 3.55 (dd, J = 9.5, 8.1 Hz, 1H), 3.77 (br. s., 
1H), 6.28 (br. s., 1H), 6.61 (d, J = 7.8 Hz, 2H), 6.73 (t, J = 7.3 Hz, 1H), 7.18 (t, J = 7.8 Hz, 
2H). 13C NMR (101 MHz, CDCl3): δ 34.3, 34.6, 45.9, 47.7, 112.8, 117.9, 129.4, 147.7, 177.6. 
LCMS (ESI): tR = 0.71 min, [M+H]+ 191.3. HRMS: (C11H15N2O) [M+H]+ requires 191.1179, 
found [M+H]+ 191.1176. υmax (neat): 3335, 2924, 1682, 1602, 1499, 1321, 1262, 750, 694 
cm-1. 
 
N-(2-Methoxyethyl)aniline (7ai).37 Yellow oil (23 mg, 76% yield). Purification: silica 
chromatography, 0-6% (EtOAc + 1% Et3N)/cyclohexane. 1H NMR (400 MHz, CDCl3): δ 3.28 
(t, J = 5.3 Hz, 2H), 3.38 (s, 3H), 3.60 (t, J = 5.3 Hz, 2H), 4.00 (br. s., 1H), 6.60-6.66 (m, 2H), 
6.71 (t, J = 7.3 Hz, 1H), 7.13-7.20 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 43.5, 58.7, 71.1, 
113.1, 117.6, 129.2, 148.2. LCMS (ESI): tR = 0.90 min, [M+H]+ 152.3. υmax (neat): 3401, 
2891, 1603, 1507, 1459, 1320, 1277, 1193, 1117, 749, 693 cm-1. 
 
tert-Butyl (2-(phenylamino)ethyl)carbamate (7aj). Off-white solid (33 mg, 70% yield). 
Purification: silica chromatography, 0-12% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 83-85 °C. 
1H NMR (400 MHz, CDCl3): δ 1.45 (s, 9H), 3.22-3.29 (m, 2H), 3.32-3.41 (m, 2H), 3.94 (br. 
s., 1H), 4.77 (br. s., 1H), 6.61 (d, J = 8.3 Hz, 2H), 6.71 (t, J = 7.3 Hz, 1H), 7.13-7.21 (m, 2H). 
13C NMR (101 MHz, CDCl3): δ 28.4, 40.2, 44.4, 79.6, 112.8, 117.6, 129.3, 148.0, 156.4. 
LCMS (ESI): tR = 1.11 min, [M+H]+ 237.4. HRMS: (C13H21N2O2) [M+H]+ requires 237.1598, 
found [M+H]+ 237.1602. υmax (neat): 3380, 2977, 1691, 1604, 1509, 1366, 1253, 1169, 989, 
749, 693 cm-1. 
 
N-(2-(1,3-Dioxolan-2-yl)ethyl)aniline (7ak). Light brown oil (30 mg, 78% yield). 
Purification: silica chromatography, 0-6% (EtOAc + 1% Et3N)/cyclohexane.  1H NMR (400 
MHz, CDCl3): δ 2.01 (td, J = 6.4, 4.5 Hz, 2H), 3.27 (t, J = 6.5 Hz, 2H), 3.83-3.91 (m, 2H), 
3.93-4.01 (m, 2H), 4.05 (br. s., 1H), 4.98 (t, J = 4.5 Hz, 1H), 6.61 (d, J = 7.8 Hz, 2H), 6.68 (t, 
J = 7.3 Hz, 1H), 7.16 (dd, J = 8.3, 7.3 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 33.1, 39.3, 
64.9, 103.8, 112.8, 117.3, 129.2, 148.4. LCMS (ESI): tR = 0.95 min, [M+H]+ 194.3. HRMS 
(ESI): (C11H16NO2) [M+H]+ requires 194.1176, found [M+H]+ 194.1177. υmax (neat): 3400, 
2884, 1603, 1508, 1413, 1319, 1266, 1180, 1139, 1031, 944, 750, 694 cm-1. 
 
N-((1,3,5-Trimethyl-1H-pyrazol-4-yl)methyl)aniline (7al).42 White solid (39 mg, 91% yield). 
Purification: silica chromatography, 0-100% (EtOAc + 1% Et3N)/cyclohexane. M.pt.: 106-
107 °C. 1H NMR (400 MHz, CDCl3): δ 2.21 (s, 3H), 2.21 (s, 3H), 3.41 (br. s., 1H), 3.72 (s, 
3H), 3.99 (s, 2H), 6.65 (dd, J = 8.4, 0.9 Hz, 2H), 6.69-6.75 (m, 1H), 7.16-7.23 (m, 2H). 13C 
NMR (101 MHz, CDCl3): δ 9.6, 11.7, 35.8, 38.1, 112.7, 113.5, 117.4, 129.3, 137.6, 146.3, 
148.4. LCMS (ESI): tR = 0.98 min, [M+H]+ 216.3. υmax (neat): 3300, 2925, 2823, 1601, 1511, 
1470, 1436, 1384, 1317, 1256, 1177, 1150, 1098, 1069, 990, 870, 750, 697 cm-1. 
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4 Å MS, 80 °Calkyl, aryl




•  Efficient with alkyl and aryl amines








•  Broad substrate scope
